226 related articles for article (PubMed ID: 12830336)
1. Ceftriaxone-associated nephrolithiasis and biliary pseudolithiasis in a child.
Prince JS; Senac MO
Pediatr Radiol; 2003 Sep; 33(9):648-51. PubMed ID: 12830336
[TBL] [Abstract][Full Text] [Related]
2. Nephrolithiasis in a child with acute pyelonephritis. Ceftriaxone-induced nephrolithiasis and biliary pseudolithiasis.
Tasic V; Sofijanova A; Avramoski V
Pediatr Nephrol; 2005 Oct; 20(10):1510-1, 1512-3. PubMed ID: 16082553
[No Abstract] [Full Text] [Related]
3. Complications of ceftriaxone-associated biliary pseudolithiasis and neprolithiasis: a case report.
Sienra MC; Pereira Núñez D; Pacheco H; Juambeltz C
Cir Pediatr; 2020 Jul; 33(3):149-152. PubMed ID: 32657101
[TBL] [Abstract][Full Text] [Related]
4. Ceftriaxone-associated nephrolithiasis and biliary pseudolithiasis.
de Moor RA; Egberts AC; Schröder CH
Eur J Pediatr; 1999 Dec; 158(12):975-7. PubMed ID: 10592073
[TBL] [Abstract][Full Text] [Related]
5. Comparative evaluation of ceftriaxone- and cefotaxime-induced biliary pseudolithiasis or nephrolithiasis: A prospective study in 154 children.
Ustyol L; Bulut MD; Agengin K; Bala KA; Yavuz A; Bora A; Demiroren K; Dogan M
Hum Exp Toxicol; 2017 Jun; 36(6):547-553. PubMed ID: 27402682
[TBL] [Abstract][Full Text] [Related]
6. Nephrolithiasis associated with ceftriaxone therapy: a prospective study in 51 children.
Avci Z; Koktener A; Uras N; Catal F; Karadag A; Tekin O; Degirmencioglu H; Baskin E
Arch Dis Child; 2004 Nov; 89(11):1069-72. PubMed ID: 15499067
[TBL] [Abstract][Full Text] [Related]
7. Ceftriaxone associated nephrolithiasis: a prospective study in 284 children.
Mohkam M; Karimi A; Gharib A; Daneshmand H; Khatami A; Ghojevand N; Sharifian M
Pediatr Nephrol; 2007 May; 22(5):690-4. PubMed ID: 17226043
[TBL] [Abstract][Full Text] [Related]
8. Re: Pediatric ceftriaxone nephrolithiasis.
Avci Z; Karadag A; Odemis E; Catal F
J Urol; 2005 Sep; 174(3):1153. PubMed ID: 16094092
[No Abstract] [Full Text] [Related]
9. [Gallstones in association with the use of ceftriaxone in children].
Rodríguez Rangel DA; Pinilla Orejarena AP; Bustacara Diaz M; Henao García L; López Cadena A; Montoya Camargo R; Moreno LA
An Pediatr (Barc); 2014 Feb; 80(2):77-80. PubMed ID: 23759541
[TBL] [Abstract][Full Text] [Related]
10. Ceftriaxone-induced biliary pseudolithiasis and urinary bladder sludge.
Acun C; Erdem LO; Sogut A; Erdem CZ; Tomac N; Gundogdu S
Pediatr Int; 2004 Jun; 46(3):368-70. PubMed ID: 15151561
[No Abstract] [Full Text] [Related]
11. [Reversible ceftriaxone-associated biliary pseudolithiasis in three children with renal diseases].
Zhong XH; Chen H; Yao Y; Zhuo XW; Huang JP; Xiao HJ; Ai Y
Zhonghua Er Ke Za Zhi; 2010 Mar; 48(3):216-9. PubMed ID: 20426960
[TBL] [Abstract][Full Text] [Related]
12. Sonographic assessment of ceftriaxone-associated biliary pseudolithiasis in Chinese children.
Meng D; Cao Y; Fu J; Chen R; Lu L; Tu Y
J Int Med Res; 2010; 38(6):2004-10. PubMed ID: 21227004
[TBL] [Abstract][Full Text] [Related]
13. Acute urine retention induced by ceftriaxone.
Akl KF; Masri AT; Hjazeen MM
Saudi J Kidney Dis Transpl; 2011 Nov; 22(6):1226-8. PubMed ID: 22089789
[TBL] [Abstract][Full Text] [Related]
14. Ceftriaxone-associated biliary pseudolithiasis in children: do we know enough?
Cuzzolin L; Oggiano AM; Clemente MG; Locci C; Antonucci L; Antonucci R
Fundam Clin Pharmacol; 2021 Feb; 35(1):40-52. PubMed ID: 32492204
[TBL] [Abstract][Full Text] [Related]
15. Fasting and bed rest, even for a relatively short period, are risk factors for ceftriaxone-associated pseudolitiasis.
Murata S; Aomatsu T; Yoden A; Tamai H
Pediatr Int; 2015 Oct; 57(5):942-6. PubMed ID: 25907455
[TBL] [Abstract][Full Text] [Related]
16. Progressive Pseudolithiasis Associated with the Intravenous Administration of Ceftriaxone in Patients with Central Nervous System Infections.
Tsukagoshi S; Ishizawa K; Hirayanagi K; Nagamine S; Makioka K; Fujita Y; Ikeda Y
Intern Med; 2017 Dec; 56(23):3189-3192. PubMed ID: 29021458
[TBL] [Abstract][Full Text] [Related]
17. Ceftriaxone-associated biliary pseudolithiasis in paediatric surgical patients.
Ceran C; Oztoprak I; Cankorkmaz L; Gumuş C; Yildiz T; Koyluoglu G
Int J Antimicrob Agents; 2005 Mar; 25(3):256-9. PubMed ID: 15737522
[TBL] [Abstract][Full Text] [Related]
18. Ceftriaxone-associated biliary pseudolithiasis in children.
Biner B; Oner N; Celtik C; Bostancioğlu M; Tunçbilek N; Güzel A; Karasalihoğlu S
J Clin Ultrasound; 2006 Jun; 34(5):217-22. PubMed ID: 16673364
[TBL] [Abstract][Full Text] [Related]
19. Ceftriaxone-associated Pseudolithiasis in the Gallbladder and Bile Duct of an Elderly Patient.
Yamabe A; Irisawa A; Wakabayashi H; Tsunoda T; Tominaga K
Intern Med; 2020 Nov; 59(21):2725-2728. PubMed ID: 32669492
[TBL] [Abstract][Full Text] [Related]
20. Biliary sludge and hyperbilirubinemia associated with ceftriaxone in an adult: case report and review of the literature.
Bickford CL; Spencer AP
Pharmacotherapy; 2005 Oct; 25(10):1389-95. PubMed ID: 16185184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
